Wilbanks Smith & Thomas Asset Management’s Bausch Health BHC Stock Holding History

Wilbanks Smith & Thomas Asset Management’s Portfolio BHC Stock Details BHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-8,206	Closed	-$834K	–	285
2015 Q4	$834K	Sell	8,206 -90	-1%	-$10.1K	0.08%	132
2015 Q3	$1.48M	Buy	8,296 +35	+0.4%	+$8.16K	0.21%	82
2015 Q2	$1.83M	Buy	8,261 +56	+0.7%	+$12.4K	0.18%	84
2015 Q1	$1.63M	Sell	8,205 -13	-0.2%	-$2.31K	0.16%	94
2014 Q4	$1.18M	Sell	8,218 -528	-6%	-$71K	0.12%	109
2014 Q3	$1.15M	Sell	8,746 -28	-0.3%	-$3.34K	0.13%	111
2014 Q2	$1.11M	Buy	8,774 +127	+1%	+$16.2K	0.12%	108
2014 Q1	$1.14M	Buy	8,647 +411	+5%	+$56.2K	0.13%	103
2013 Q4	$967K	Sell	8,236 -74	-0.9%	-$8.11K	0.11%	115
2013 Q3	$867K	Buy	8,310 +45	+0.5%	+$4.38K	0.12%	118
2013 Q2	$711K	Buy	+8,265	New	+$651K	0.11%	123

Other funds holding BHC

RCG

Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return

PSCM

Pershing Square Capital Management New York $13.7B AUM 13.45% 1-Year Est. Return

ValueAct Holdings San Francisco, California $5.71B AUM 7.41% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Wilbanks Smith & Thomas Asset Management's BHC Position: Q1 2016 in Review

Wilbanks Smith & Thomas Asset Management sold out of Bausch Health (BHC) in Q1 2016, closing a stake of 8,206 shares — an estimated $834K sold.

Wilbanks Smith & Thomas Asset Management first reported a position in BHC in Q2 2013 and held it in 11 quarters. The position peaked at $1.83M in Q2 2015. 389 funds tracked by Wall St. Rank hold BHC as of Q1 2016.

Wilbanks Smith & Thomas Asset Management reported no remaining Bausch Health position as of Q1 2016 after selling out during the quarter.
Wilbanks Smith & Thomas Asset Management sold 8,206 Bausch Health shares in Q1 2016, an estimated $834K.
Wilbanks Smith & Thomas Asset Management first reported a position in Bausch Health in Q2 2013 and held it in 11 quarters.
Wilbanks Smith & Thomas Asset Management's Bausch Health position peaked at $1.83M in Q2 2015.
389 funds tracked by Wall St. Rank held Bausch Health as of Q1 2016.

Based on Wilbanks Smith & Thomas Asset Management's 13F filing for Q1 2016, filed 25 Apr 2016.